Interaction of zincite, alpha-terpineol, geranyl acetate, linalool, myrcenol, terpinolene, and thymol with virulence factors of Escherichia coli, Mycobacterium tuberculosis, Pseudomonas aeruginosa, and Staphylococcus aureus
BACKGROUND: Based on gas chromatography - mass spectrometry (GC-MS) results of a previous study, six metabolites including alpha-terpineol, geranyl acetate, linalool, myrcenol, terpinolene, and thymol showed significantly higher amounts relative to other metabolites.
METHODS: A continuation of the previous study, the interaction of these metabolites with the main virulence factors of P. aeruginosa (pseudomonas elastase and exotoxin A), Staphylococcus aureus (alpha-hemolysin and protein 2a), Mycobacterium tuberculosis (ESX-secreted protein B and the serine/threonine protein kinase), and Escherichia coli (heat-labile enterotoxin and Shiga toxin) were evaluated by molecular docking study and molecular simulation.
RESULTS: In the case of Shiga toxin, higher and lower binding affinities were related to alpha-terpinolene and zincite with values of -5.8 and -2.6 kcal/mol, respectively. For alpha-hemolysin, terpinolene and alpha-terpinolene demonstrated higher binding affinities with similar energies of -5.9 kcal/mol. Thymol and geranyl acetate showed lower binding energy of -5.7 kcal/mol toward protein 2a. Furthermore, thymol had a higher binding affinity toward heat-labile enterotoxin and ESX-secreted protein B with values of -5.9 and -6.1 kcal/mol, respectively.
CONCLUSIONS: It is concluded that the availability of secondary metabolites of A. haussknechtii surrounding zinc oxide (ZnO) NPs can hinder P. aeruginosa by inactivating Pseudomonas elastase and exotoxin.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
---|---|
Enthalten in: |
Expert review of anti-infective therapy - 22(2024), 4 vom: 05. Apr., Seite 253-272 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Alavi, Mehran [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 08.04.2024 Date Revised 08.04.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/14787210.2023.2238123 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM359616968 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM359616968 | ||
003 | DE-627 | ||
005 | 20240408232035.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/14787210.2023.2238123 |2 doi | |
028 | 5 | 2 | |a pubmed24n1369.xml |
035 | |a (DE-627)NLM359616968 | ||
035 | |a (NLM)37461145 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Alavi, Mehran |e verfasserin |4 aut | |
245 | 1 | 0 | |a Interaction of zincite, alpha-terpineol, geranyl acetate, linalool, myrcenol, terpinolene, and thymol with virulence factors of Escherichia coli, Mycobacterium tuberculosis, Pseudomonas aeruginosa, and Staphylococcus aureus |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 08.04.2024 | ||
500 | |a Date Revised 08.04.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a BACKGROUND: Based on gas chromatography - mass spectrometry (GC-MS) results of a previous study, six metabolites including alpha-terpineol, geranyl acetate, linalool, myrcenol, terpinolene, and thymol showed significantly higher amounts relative to other metabolites | ||
520 | |a METHODS: A continuation of the previous study, the interaction of these metabolites with the main virulence factors of P. aeruginosa (pseudomonas elastase and exotoxin A), Staphylococcus aureus (alpha-hemolysin and protein 2a), Mycobacterium tuberculosis (ESX-secreted protein B and the serine/threonine protein kinase), and Escherichia coli (heat-labile enterotoxin and Shiga toxin) were evaluated by molecular docking study and molecular simulation | ||
520 | |a RESULTS: In the case of Shiga toxin, higher and lower binding affinities were related to alpha-terpinolene and zincite with values of -5.8 and -2.6 kcal/mol, respectively. For alpha-hemolysin, terpinolene and alpha-terpinolene demonstrated higher binding affinities with similar energies of -5.9 kcal/mol. Thymol and geranyl acetate showed lower binding energy of -5.7 kcal/mol toward protein 2a. Furthermore, thymol had a higher binding affinity toward heat-labile enterotoxin and ESX-secreted protein B with values of -5.9 and -6.1 kcal/mol, respectively | ||
520 | |a CONCLUSIONS: It is concluded that the availability of secondary metabolites of A. haussknechtii surrounding zinc oxide (ZnO) NPs can hinder P. aeruginosa by inactivating Pseudomonas elastase and exotoxin | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Biocompatible NPs | |
650 | 4 | |a Zinc oxide NPs | |
650 | 4 | |a medicinal plant species | |
650 | 4 | |a multidrug-resistant bacteria | |
650 | 4 | |a primary and secondary metabolites | |
650 | 7 | |a 7-hydroxy-7-methyl-3-methylene-1-octene |2 NLM | |
650 | 7 | |a X4XS5MYJ20 |2 NLM | |
650 | 7 | |a Thymol |2 NLM | |
650 | 7 | |a 3J50XA376E |2 NLM | |
650 | 7 | |a geranyl acetate |2 NLM | |
650 | 7 | |a 3W81YG7P9R |2 NLM | |
650 | 7 | |a terpinolene |2 NLM | |
650 | 7 | |a N9830X5KSL |2 NLM | |
650 | 7 | |a linalool |2 NLM | |
650 | 7 | |a D81QY6I88E |2 NLM | |
650 | 7 | |a alpha-terpineol |2 NLM | |
650 | 7 | |a 21334LVV8W |2 NLM | |
650 | 7 | |a Virulence Factors |2 NLM | |
650 | 7 | |a Hemolysin Proteins |2 NLM | |
650 | 7 | |a Enterotoxins |2 NLM | |
650 | 7 | |a Exotoxins |2 NLM | |
650 | 7 | |a Shiga Toxins |2 NLM | |
650 | 7 | |a Pancreatic Elastase |2 NLM | |
650 | 7 | |a EC 3.4.21.36 |2 NLM | |
650 | 7 | |a Acetates |2 NLM | |
650 | 7 | |a Cyclohexane Monoterpenes |2 NLM | |
650 | 7 | |a Monoterpenes |2 NLM | |
650 | 7 | |a Acyclic Monoterpenes |2 NLM | |
650 | 7 | |a Octanols |2 NLM | |
700 | 1 | |a Ashengroph, Morahem |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Expert review of anti-infective therapy |d 2003 |g 22(2024), 4 vom: 05. Apr., Seite 253-272 |w (DE-627)NLM151540101 |x 1744-8336 |7 nnns |
773 | 1 | 8 | |g volume:22 |g year:2024 |g number:4 |g day:05 |g month:04 |g pages:253-272 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/14787210.2023.2238123 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 22 |j 2024 |e 4 |b 05 |c 04 |h 253-272 |